BOARD MEETING OUCTOME AS PER REGULATION 30SEBI(LODR)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has filed the outcome of its Board Meeting with BSE as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) regulations. The headline indicates the company disclosed decisions taken at a recent board meeting, but specific details, agenda items, financial figures, or resolutions passed have not been included in the provided text. Retail investors should look up the full announcement on the BSE corporate filings page to understand what the board decided — this could range from approval of quarterly results, fundraising, expansion, or governance matters.
Without the detailed contents of the board meeting, the actual impact on shareholders or stock price cannot be determined. Investors should check the full filing to assess whether the board's decisions are materially positive, neutral, or negative for the company.